Agency Information Collection Request. 60-Day Public Comment Request, 55164-55165 [2019-22416]
Download as PDF
<![CDATA[
55164
Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden
per response
(in hours)
Total
burden
hours
EHE Triannual Module .........................................................
47
3
141
1
141
Total ..............................................................................
47
........................
141
........................
141
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–22395 Filed 10–11–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Single Source Award to the
Rural Communities Opioid Response
Program—Technical Assistance
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
The Rural Communities
Opioid Response Program—Technical
Assistance (RCORP-TA), program
supports rural consortiums and opioid
recipients that provide treatment for and
prevention of substance use disorder
with a focus on opioid use disorder. The
TA efforts will enhance the
organizational and infrastructural
capacity of multi-sector consortiums at
the community, county, state, and/or
regional levels. The overall goal is the
reduction of morbidity and mortality
associated with opioid overdoses in
high-risk rural communities. The
RCORP-TA award recipient provides
resources and expertise in support of
the execution of the following focus
areas: (1) Prevention—reducing the
occurrence of opioid use disorder (OUD)
among new and at-risk users as well as
fatal opioid-related overdoses through
community and provider education and
harm reduction measures including the
strategic placement of overdose
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
VerDate Sep<11>2014
16:25 Oct 11, 2019
Jkt 250001
reversing devices, such as naloxone; (2)
treatment—implementing or expanding
access to evidence-based practices for
opioid addiction/OUD treatment such as
medication-assisted treatment,
including developing strategies to
eliminate or reduce treatment costs to
uninsured and underinsured patients;
and (3) recovery—expanding peer
recovery and treatment options to help
people start and stay in recovery.
The RCORP-TA initiative is part of a
multi-year, opioid focused effort by
HRSA that will include: Improving
access to and recruitment of new
substance use disorder providers;
building sustainable treatment
resources; increasing the use of
telehealth; establishing cross-sector
community partnerships; implementing
new models of care, including
integrated behavioral health; and
providing technical assistance.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: JBS
International, Inc. (U6BRH32364).
Amount of Award: $3,000,000.
Project Period: September 30, 2019–
September 29, 2020.
CFDA Number: 93.912.
Authority: Public Health Service Act,
Section 330A (f) (42 U.S.C. 254c (f)), as
amended.
Justificaton: Additional funding will
be awarded annually through FY 2022
contingent on satisfactory performance
of the recipient, and continued
availability of funds.
The RCORP-TA program was
announced under HRSA–18–124. In FY
2018, HRSA funded this program at up
to $3,000,000 per year to one awardee,
JBS International, Inc., for a period of
performance for up to 4 years. RCORPTA program was competed in late FY
2018. At the time of the award, RCORPTA recipient was expected to provide
technical assistance to 75 opioid award
recipients. The current RCORP-TA
recipient is expected to support
approximately 318 opioid award
recipients. As a result of this increase in
opioid award recipients, the RCORP-TA
recipient will need additional funds to
expand its capacity to provide TA
services. Supplemental funding is
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
required for the current RCOPR-TA
award recipient to provide TA services
to the additional 243 opioid award
recipients. These additional funds will
enable the current recipient to provide
high quality TA.
Further information on the Telehealth
Focused Rural Health Research Center is
available at: https://www.hrsa.gov/
ruralhealth/programopportunities/
fundingopportunities/
default.aspx?id=482de32c-8b8d-4960bb86-caad8c9d6905
FOR FURTHER INFORMATION CONTACT:
Marcia Colburn, Program Coordinator,
RCORP-TA, (301) 443–3261, MColburn@
hrsa.gov.
Dated: October 4, 2019.
Thomas J. Engels,
Acting Administrator.
[FR Doc. 2019–22434 Filed 10–11–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990-xxxx]
Agency Information Collection
Request. 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before December 16,
2019.
SUMMARY:
Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–New–
60D, and project title for reference, to
Sherrette Funn, the Reports Clearance
Officer, Sherrette.funn@hhs.gov, or call
202–795–7714.
ADDRESSES:
E:\FR\FM\15OCN1.SGM
15OCN1
55165
Federal Register / Vol. 84, No. 199 / Tuesday, October 15, 2019 / Notices
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Medical
Countermeasures.gov.
SUPPLEMENTARY INFORMATION:
Type of Collection: OMB No. 0990–
0323—Extension—
Abstract: The Office of the Assistant
Secretary for Preparedness and
Response (ASPR), Office of the
Biomedical Advanced Research and
Development Authority (BARDA), is
requesting an approval on an extension
by OMB on a currently approved
information collection. The purpose of
this collection is, in order to route
product developers to the most
appropriate personnel within the
Department of Health and Human
Services (HHS), HHS collects some
basic information about the company’s
product through Medical
Countermeasures.gov. Using this
information and a routing system that
has been developed with input from
participating agencies within HHS,
including the Office of the Assistant
Secretary for Preparedness and
Response (ASPR), the Centers for
Disease Control and Prevention (CDC),
the Food and Drug Administration
(FDA), and the National Institutes of
Health (NIH), Medical
Countermeasures.gov routes the meeting
request to the appropriate person within
HHS. ASPR is requesting an extension
by OMB for a three-year clearance.
Type of respondent: Developers of
medical countermeasures to naturally
occurring and intentional public health
threats visit the site on a monthly basis.
ANNUALIZED BURDEN HOUR TABLE
Meeting Request ...................
Developers of medical countermeasures to
naturally occurring and intentional public
health threats..
245
1
10/60
41
Total ...............................
.......................................................................
........................
........................
........................
41
[FR Doc. 2019–22416 Filed 10–11–19; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
Respondents
(if necessary)
Terry Clark,
Asst Paperwork Reduction Act Reports
Clearance Officer,Office of the Secretary.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: T32
Special Emphasis Panel.
Date: October 29, 2019.
VerDate Sep<11>2014
19:29 Oct 11, 2019
Jkt 250001
Number of
respondents
Number of
responses
per
respondent
Forms
(if necessary)
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Branch, National Institute
of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Room 820, Bethesda, MD
20817, 301–827–7835, yasuko.furumoto@
nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: AMS
Member Conflict.
Date: October 31, 2019.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 818, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Kathy Salaita, SCD, Chief,
Scientific Review Branch, DHHS/NIH/
NIAMS, One Democracy Plaza, Suite 800,
6701 Democracy Blvd. MSC 4872, Bethesda,
MD 20892, 301–594–5033, Kathy.Salaita@
nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: Rare
Diseases SBIR Review Meeting.
Date: November 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Total burden
hours
Contact Person: Yin Liu, Ph.D., MD,
Scientific Review Branch, National Institute
of Arthritis and Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd., Room 824, Bethesda, MD
20817, 301–594–8919, liuy@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: October 8, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–22382 Filed 10–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 84, Number 199 (Tuesday, October 15, 2019)]
[Notices]
[Pages 55164-55165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22416]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-xxxx]
Agency Information Collection Request. 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before December 16,
2019.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 795-7714.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D, and
project title for reference, to Sherrette Funn, the Reports Clearance
Officer, [email protected], or call 202-795-7714.
[[Page 55165]]
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Medical Countermeasures.gov.
Type of Collection: OMB No. 0990-0323--Extension--
Abstract: The Office of the Assistant Secretary for Preparedness
and Response (ASPR), Office of the Biomedical Advanced Research and
Development Authority (BARDA), is requesting an approval on an
extension by OMB on a currently approved information collection. The
purpose of this collection is, in order to route product developers to
the most appropriate personnel within the Department of Health and
Human Services (HHS), HHS collects some basic information about the
company's product through Medical Countermeasures.gov. Using this
information and a routing system that has been developed with input
from participating agencies within HHS, including the Office of the
Assistant Secretary for Preparedness and Response (ASPR), the Centers
for Disease Control and Prevention (CDC), the Food and Drug
Administration (FDA), and the National Institutes of Health (NIH),
Medical Countermeasures.gov routes the meeting request to the
appropriate person within HHS. ASPR is requesting an extension by OMB
for a three-year clearance.
Type of respondent: Developers of medical countermeasures to
naturally occurring and intentional public health threats visit the
site on a monthly basis.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Forms (if necessary) Respondents (if Number of responses per Average burden Total burden
necessary) respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
Meeting Request............... Developers of 245 1 10/60 41
medical
countermeasures
to naturally
occurring and
intentional
public health
threats..
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 41
----------------------------------------------------------------------------------------------------------------
Terry Clark,
Asst Paperwork Reduction Act Reports Clearance Officer,Office of the
Secretary.
[FR Doc. 2019-22416 Filed 10-11-19; 8:45 am]
BILLING CODE 4150-04-P
